Learning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels
- 3 May 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 23 (5) , 547-552
Abstract
Introduction: Artificial intelligence or machine learning (AI/ML) based systems can help personalize prescribing decisions for individual patients. The recommendations of these clinical decision support systems must relate to the "label" of the medicines involved. The label of a medicine is an approved guide that indicates how to prescribe the drug in a safe and effective manner. Areas covered: The label for a medicine may evolve as new information on drug safety and effectiveness emerges, leading to the addition or removal of warnings, drug-drug interactions, or to permit new indications. However, the speed at which these updates are made to these AI/ML recommendation systems may be delayed and could influence the safety of prescribing decisions. This article explores the need to keep AI/ML tools 'in sync' with any label changes. Additionally, challenges relating to medicine availability and geographical suitability are discussed. Expert Opinion: These considerations highlight the important role that pharmacoepidemiologists and drug safety professionals must play within the monitoring and use of these tools. Furthermore, these issues highlight the guiding role that regulators need to have in planning and oversight of these tools.Keywords
This publication has 12 references indexed in Scilit:
- Clinical decision support systems to improve drug prescription and therapy optimisation in clinical practice: a scoping reviewBMJ Health & Care Informatics, 2023
- Determinants of implementing artificial intelligence-based clinical decision support tools in healthcare: a scoping review protocolBMJ Open, 2023
- Explainability and causability for artificial intelligence-supported medical image analysis in the context of the European In Vitro Diagnostic RegulationNew Biotechnology, 2022
- Medical artificial intelligenceCommunications of the ACM, 2021
- An overview of clinical decision support systems: benefits, risks, and strategies for successnpj Digital Medicine, 2020
- Artificial intelligence in healthcareNature Biomedical Engineering, 2018
- Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety WithdrawalsDrug Safety, 2017
- Automation bias and verification complexity: a systematic reviewJournal of the American Medical Informatics Association, 2016
- Different Black Box Warning Labeling for Same-Class DrugsJournal of General Internal Medicine, 2011
- Clinical Decision Support Systems2007